Related Experiment Video
Updated: Mar 25, 2026

Mechanical Control of Relaxation Using Intact Cardiac Trabeculae
Published on: February 17, 2023
The Muscle-Bound Heart
Marwan M Refaat1, Akl C Fahed2, Sylvana Hassanieh3
1Cardiac Electrophysiology, Cardiology, Department of Internal Medicine, American University of Beirut Faculty of Medicine and Medical Center, PO Box 11-0236, Riad El-Solh, Beirut 1107 2020, Lebanon; Department of Biochemistry and Molecular Genetics, American University of Beirut Faculty of Medicine and Medical Center, PO Box 11-0236, Riad El-Solh, Beirut 1107 2020, Lebanon; Department of Biochemistry and Molecular Genetics, American University of Beirut, Beirut, Lebanon; Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
Insights
Hypertrophic cardiomyopathy (HCM) is a genetic heart condition with varied symptoms and causes, posing risks, especially for young adults. Ongoing research aims to better understand HCM
Area of Science:
- Cardiology
- Genetics
- Personalized Medicine
Background:
- Hypertrophic cardiomyopathy (HCM) is a prevalent genetic cardiac disorder.
- It presents with diverse clinical manifestations and genetic underpinnings.
- HCM poses significant risks, particularly to young adults.
Observation:
- Extensive research is underway to correlate patient phenotypes with genotypes.
- Understanding these links is crucial for improved disease management and complication control.
- The complete pathogenic mechanisms of HCM remain incompletely understood.
Findings:
- Current therapeutic strategies for HCM are not definitive due to incomplete mechanistic understanding.
- Categorizing patients based on genotype-phenotype links is an active area of investigation.
- Further research is essential for a comprehensive understanding of HCM.
Implications:
- Advancing research into HCM mechanisms and genetics can lead to more targeted therapies.
- Improved patient stratification may enhance clinical outcomes and disease prognosis.
- A complete picture of HCM will facilitate the development of definitive treatment protocols.
Abstract:
Hypertrophic cardiomyopathy (HCM) is a familial cardiac disease manifested in a wide phenotype and diverse genotype and, thus, presenting unpredictable risks mainly on young adults. Extensive studies are being conducted to categorize patients and link phenotype with genotype for a better management and control of the disease with all its complications. Because the full mechanisms behind HCM are still not revealed, therapeutics are not definitive. Further research is to be conducted for the generation of a complete picture and directed therapy for HCM.
Related Concept Videos
Structure of Cardiac Muscles
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Anatomy of the Heart
Anatomy of the Heart
The heart has three layers: the innermost endocardium, the muscular myocardium, and the outer epicardium, all working together for optimal cardiac function.
Chambers of the Heart
The heart is made up of four...
Location and Orientation of the Heart
Specialized Characteristics of Cardiac Muscles
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy...
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...

